iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference

Insight Molecular Diagnostics to Present at Lake Street 10th Annual Best Ideas Growth Conference

Insight Molecular Diagnostics Inc. announced its participation in the upcoming Lake Street Capital Markets 10th Annual Best Ideas Growth Conference scheduled for September 10, 2026, where its CEO and CFO will engage in one-on-one investor meetings in New York City.

IMDX

Summarize with

ChatGPT Perplexity Claude Grok Gemini

Key Points

Insight Molecular Diagnostics is actively engaging with investors through a significant growth-focused conference.
Top executives, including CEO Josh Riggs and CFO Andrea James, will represent the company, indicating a strategic push for investor relations.
The company's mission focuses on democratizing access to advanced molecular diagnostic testing, targeting improved patient outcomes, highlighting its role in healthcare innovation.

NASHVILLE, Tenn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced participation in the upcoming Lake Street Capital Markets 10th Annual Best Ideas Growth “BIG10” Conference taking place September 10th, 2026 in New York.

Event: Lake Street Capital Markets 10th Annual Best Ideas Growth “BIG10” Conference
Who: Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James
Date: Thursday, September 10, 2026
Location: Metropolitan Club, New York City
Format: One-on-one meetings

Investors wishing to meet with IMDX management are encouraged to reach out to their Lake Street sales representative.

About Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.imdxinc.com/ for more information.

GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Insight Molecular Diagnostics Inc.

Investor Contact:
Alexandra Grossman
LifeSci Advisors LLC
imdx@lifesciadvisors.com

Risks

The article does not discuss specific financial results or new product launches, so near-term market impact may be limited.
Participation in investor conferences does not guarantee new investments or stock price appreciation, as market reception depends on broader fundamental and sector conditions.
The molecular diagnostics and healthcare sectors face competitive pressures and regulatory risks, which might impact company performance despite investor outreach efforts.

Menu

iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference

Key Points

Risks

More from Press Releases